Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials

Summary and Infographic: Drug treatments for covid-19: living systematic review and network meta-analysis – The BMJ

Original guideline: Therapeutics and COVID-19: living guideline – World Health Organization

News release: WHO advises that ivermectin only be used to treat COVID-19 within clinical trials – World Health Organization

Commentary: WHO joins Europe, Merck in recommending against ivermectin for COVID-19 – Reuters

Commentary on Twitter

?Our updated @WHO #LivingGuidance on #COVID19 now adding recommandation on #ivermectin to previous recs on #steroids #remdesivir #lopinavir #Hydroxychloroquine

?https://t.co/eV7BtVrvAf
?https://t.co/G3Eu18Vg0s#MichaelJacobs @Bram_Rochwerg @PerVandvik @diazjv @bmj_latest https://t.co/qdrBQIZK8e pic.twitter.com/s9TkO1afYs

— Thomas Agoritsas, MD PhD (@ThomasAgoritsas) March 31, 2021